ABBV Jan 2024 160.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
At close: 01:38PM EDT
| Previous close | 14.00 |
| Open | 14.65 |
| Bid | 14.90 |
| Ask | 15.80 |
| Strike | 160.00 |
| Expiry date | 2024-01-19 |
| Day's range | 14.65 - 15.45 |
| Contract range | N/A |
| Volume | |
| Open interest | 395 |
- Zacks
Pharma Stock Roundup: FDA OK's Expanded Use of ABBV, MRK, NVS Drugs, Other Updates
The FDA approves expanded use of AbbVie's (ABBV) Skyrizi, Merck's (MRK) Vaxneuvance vaccine and Novartis's (NVS) cancer combination drugs, Tafinlar (dabrafenib) + Mekinist (trametinib).
- PR Newswire
New Survey Offers Perspective on Mental and Emotional Journey for Patients Diagnosed with Slow-Growing Blood Cancer
AbbVie today shared findings from the newly launched Emotional Impact Report, a survey of more than 300 chronic lymphocytic leukemia (CLL) patients, caregivers and healthcare providers (HCPs), which uncovered insights about the emotional journey associated with a CLL diagnosis.
- PR Newswire
AbbVie Declares Quarterly Dividend
The board of directors of AbbVie Inc. (NYSE: ABBV) today declared a quarterly cash dividend of $1.41 per share.
© 2022 Yahoo. All rights reserved.
